Injectable Platelet-Rich Fibrin With or Without Hyaluronic Acid After Arthrocentesis for Temporomandibular Joint Internal Derangement: A Randomised Controlled Trial

Purpose To compare six-month clinical outcomes of arthrocentesis alone with arthrocentesis plus injectable platelet-rich fibrin (I-PRF), hyaluronic acid (HA), or both (I-PRF + HA) in Wilkes stage II–III temporomandibular joint (TMJ) internal derangement. Methods In this prospective four-arm randomised trial, 56 patients with unilateral TMJ internal derangement (14 per group) were followed for six months. The primary outcome was pain intensity (visual analogue scale, VAS). Secondary outcomes were mandibular range of motion, quality of life (Oral Health Impact Profile-14, OHIP-14) and rescue analgesic use. Masticatory efficiency and ultrasound-assessed disc position were exploratory. Results At six months, mean VAS in the I-PRF + HA group fell from 7.5 to 1.9, compared with 4.2 after arthrocentesis alone (p < 0.001 across groups). Maximum mouth opening reached 43.6 ± 2.5 mm in the combination group versus 36.3 ± 2.9 mm after arthrocentesis alone (p < 0.001). OHIP-14 improved by 12.8 points in the combination group. Rescue analgesic use was lowest with the combination (1.8 ± 0.89 tablets), significantly lower than with arthrocentesis alone or HA alone (p < 0.01) but not than with I-PRF alone (p = 0.07). The I-PRF and I-PRF + HA groups did not differ significantly at later time points. Conclusion In this small trial, I-PRF-containing regimens, particularly I-PRF + HA, were associated with greater improvements in pain and function than arthrocentesis alone or with HA alone. The added benefit of HA over I-PRF alone was not demonstrated. These preliminary findings require confirmation in larger, adequately powered trials. Trial registration: CTRI/2023/11/059991, registered 20/11/2023.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11604645/v1
Primary Topic
Temporomandibular Joint Disorders
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Injectable Platelet-Rich Fibrin With or Without Hyaluronic Acid After Arthrocentesis for Temporomandibular Joint Internal Derangement: A Randomised Controlled Trial

Uddarraju Shivaji Raju, Sravani Pampana, Kishore Moturi, Puvvada Divya et al.
Research Square
Temporomandibular Joint Disorders
preprint

Injectable Platelet-Rich Fibrin With or Without Hyaluronic Acid After Arthrocentesis for Temporomandibular Joint Internal Derangement: A Randomised Controlled Trial

Uddarraju Shivaji Raju, Sravani Pampana, Kishore Moturi, Puvvada Divya, Siva Dilip Sami, Manoj K Malya
preprint en

Abstract

Purpose To compare six-month clinical outcomes of arthrocentesis alone with arthrocentesis plus injectable platelet-rich fibrin (I-PRF), hyaluronic acid (HA), or both (I-PRF + HA) in Wilkes stage II–III temporomandibular joint (TMJ) internal derangement. Methods In this prospective four-arm randomised trial, 56 patients with unilateral TMJ internal derangement (14 per group) were followed for six months. The primary outcome was pain intensity (visual analogue scale, VAS). Secondary outcomes were mandibular range of motion, quality of life (Oral Health Impact Profile-14, OHIP-14) and rescue analgesic use. Masticatory efficiency and ultrasound-assessed disc position were exploratory. Results At six months, mean VAS in the I-PRF + HA group fell from 7.5 to 1.9, compared with 4.2 after arthrocentesis alone (p < 0.001 across groups). Maximum mouth opening reached 43.6 ± 2.5 mm in the combination group versus 36.3 ± 2.9 mm after arthrocentesis alone (p < 0.001). OHIP-14 improved by 12.8 points in the combination group. Rescue analgesic use was lowest with the combination (1.8 ± 0.89 tablets), significantly lower than with arthrocentesis alone or HA alone (p < 0.01) but not than with I-PRF alone (p = 0.07). The I-PRF and I-PRF + HA groups did not differ significantly at later time points. Conclusion In this small trial, I-PRF-containing regimens, particularly I-PRF + HA, were associated with greater improvements in pain and function than arthrocentesis alone or with HA alone. The added benefit of HA over I-PRF alone was not demonstrated. These preliminary findings require confirmation in larger, adequately powered trials. Trial registration: CTRI/2023/11/059991, registered 20/11/2023.

Research Square
College of Medical Sciences (NP), Vishnu Dental College (IN)
Temporomandibular Joint Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon